Hiroe Hu
3 presentations
-
NOVEL THERAPEUTICS WITH ENTACTOGENIC EFFECTS - A NEW FRONTIER FOR MOOD AND ANXIETY DISORDERS?
-
INTRAVENOUS KETAMINE IMPROVES SOCIAL ANHEDONIA IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION AND SUICIDAL IDEATION
-
W32. NEUROACTIVE STEROID CHANGES PRE-AND POST-KETAMINE DURING A DOUBLE-BLIND, CROSSOVER CLINICAL TRIAL: AN EXPLORATORY STUDY